Sun Pharmaceutical Industries has announced the acquisition of a 15.91% stake in Krystal Biotech for $7m.

Both companies involved in the acquisition are based in India.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Chinese pharmaceutical company Northeast Pharmaceutical Group plans to acquire another pharmaceutical company based in China through its wholly owned subsidiary for CNY120m ($17.82m).

UK-based specialist pharmaceutical company Mallinckrodt plans to acquire US-based pharmaceutical company InfaCare Pharmaceutical Corporation for an initial upfront payment of $80m.

"Chinese pharmaceutical company Northeast Pharmaceutical Group plans to acquire another pharmaceutical company based in China through its wholly owned subsidiary for CNY120m ($17.82m)."

Mallinckrodt will make additional payments of up to $345m upon achieving regulatory and sales milestones.

The acquisition will enable Mallinckrodt to expand its paediatric product portfolio.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Formosa Laboratories plans to acquire Activus Pharma through its subsidiary Formosa Pharmaceuticals from Sosei Group Corporation.

Formosa is an active pharmaceutical ingredients (APIs) manufacturer based in Taiwan, while both Activus Pharma and Sosei Group Corporation are pharmaceutical companies based in Japan.

Pharmaceutical Technology Excellence Awards - Have you nominated?

Nominations are now open for the prestigious Pharmaceutical Technology Excellence Awards - one of the industry's most recognised programmes celebrating innovation, leadership, and impact. This is your chance to showcase your achievements, highlight industry advancements, and gain global recognition. Don't miss the opportunity to be honoured among the best - submit your nomination today!

Nominate Now